Meeting report on the 13th International Conference on Human Retrovirology: Human T-cell leukemia virus research 30 years after adult T-cell leukemia

Cancer Research

Volumn 67, Issue 22, 2007, Pages 10638-10641

  Matsuoka, Masao ^a   Watanabe, Toshiki ^b   Kannagi, Mari ^c   Bangham, Charles ^d   Grassmann, Ralph ^e   Marriott, Susan J ^f   Green, Patrick ^g   Jeang, Kuan Teh ^h  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g OHIO STATE UNIVERSITY   (United States)

^h NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; PROTEIN P130; PROTEIN P30; TENOFOVIR; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; CANCER RESEARCH; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; EXPERIMENTAL MODEL; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INCIDENCE; MEDICAL PRACTICE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T CELL LEUKEMIA; VIRUS INFECTION; VIRUS ISOLATION;

ANIMALS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DELTARETROVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INFLAMMATION; LEUKEMIA, T-CELL; MICE; RETROVIRIDAE; TRANSCRIPTION, GENETIC;

EID: 36348962599     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-2587     Document Type: Conference Paper

References (9)

1. Takatsuki K. Discovery of adult T-cell leukemia. Retrovirology 2005;2:16.
2. Gallo RC. The discovery of the first human retrovirus: HTLV-1 and HTLV-2. Retrovirology 2005;2:17.
3. Yoshida M. Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene 2005;24:5931-7.
4. Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 2007;7:270-80.
5. Kwaan N, Lee TH, Chafets DM, et al. Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data. J Infect Dis 2006;194:1557-64.
6. Asquith B , Zhang Y, Mosley AJ, et al. In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection. Proc Natl Acad Sci U S A 2007;104:8035-40.
7. Komori K, Hasegawa A, Kurihara K, et al. Reduction of human T-cell leukemia virus type 1 (HTLV-1) proviral loads in rats orally infected with HTLV-1 by reimmunization with HTLV-1-infected cells. J Virol 2006;80:7375-81.
8. Hasegawa H, Sawa H, Lewis MJ, et al. Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat Med 2006;12:466-72.
9. Ohsugi T, Kumasaka T, Okada S, Urano T. The Tax protein of HTLV-1 promotes oncogenesis in not only immature T cells but also mature T cells. Nat Med 2007;13:527-8.